Creative Medical Technology Holdings, Inc. got a warning from Nasdaq for not meeting the minimum price rule.

Nov 13, 2026, 4:10 PM ETTroubleRead the original at SEC EDGAR

Bad for CELZ

CELZ faces a risk to its Nasdaq listing because its bid price failed the exchange's rule. It has until May 10, 2027, to meet the price test, and the notice has no immediate effect on its listing.

CELZ · Creative Medical Technology Holdings, Inc.

AI read · Bad for CELZ

The AI's read

If CELZ cannot get its bid back to $1.00 for 10 straight business days, Nasdaq could remove its shares from the exchange. The grace period gives it time, and the notice does not change its listing today.

Get alerts for CELZ

Follow Creative Medical Technology Holdings, Inc. (CELZ) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CELZ

Free on the App Store and Google Play, or on the web.